Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment

Dermatol Ther. 2020 Jul;33(4):e13706. doi: 10.1111/dth.13706. Epub 2020 Jun 19.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • Biological Therapy
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Italy
  • Pandemics*
  • Pneumonia, Viral*
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy
  • Psoriasis* / epidemiology
  • Respiratory Distress Syndrome* / diagnosis
  • Respiratory Distress Syndrome* / therapy
  • SARS-CoV-2